Table 2. Characteristics of sequence datasets used for development of new SSR markers.

Sequence dataset	Total number of reads	Number of good quality reads (%)	PALsa	Number of tested loci	Number of loci successfully amplified (%)
Enriched Genomic—454	556,018	18,218 (3.27%)	270	96	30 (31.2%)
Genomic—Illumina	12,000,000	923,229 (7.69%)	2,720	110	37 (33.6%)
EST—454	1,317,778	393,302 (29.85%)	397	173	41 (23.7%)

^a Potentially Amplifiable Loci (PALs).